Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets
Report Scope:
This research study analyzes the GI diagnostics and therapeutics market, offers revenue forecasts, assesses future trends and provides strategic recommendations for the success of market participants. The scope of the study is global. This report estimates market data for 2022 (the base year) and forecasts for 2023 through 2028. Figures for 2023 are estimated, except where actual results have been reported. This report includes forecasts by product type and region from 2023 through 2028.
Report Includes:
43 data tables and 66 additional tables
An overview of the global markets for gastrointestinal disease (GI) therapeutics and diagnostics.
Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028.
Discussion of the current and future market potential for GI therapeutics and diagnostics, along with an analysis of the competitive environment, regulatory scenario, and technological advances.
Estimate of the market size and revenue forecast for the global market, and corresponding market share analysis by diagnostics type, end user and region.
Facts and figures pertaining to the major market dynamics, opportunities and deterrents, emerging technologies, future prospects and the impacts of macroeconomic variables.
A look at the GI therapeutics and diagnostic options currently available as well as potential products and classes of products that are likely to have an impact.
Discussion of sustainability trends and ESG developments, with an emphasis on consumer attitudes, analysis of companies’ ESG scores, and the ESG practices followed by leading companies.
Information pertaining to the recent developments and emerging technologies in the market.
Review of current and potential treatment options and their impact on this market growth.
A look at the industry structure, competitive aspects of each product segment, increasing investment in R&D, market development strategies, and company value share analysis.
An analysis of the competitive landscape based on recent developments and segmental revenues.
Profiles of the major global players, including Takeda Pharmaceutical Co. Ltd., Johnson & Johnson Services Inc., AbbVie Inc., Sanofi, Bristol-Myers Squibb Co., and F. Hoffmann-La Roche Ltd.
ABBVIE INC.
BAYER AG
BOSTON SCIENTIFIC CORP.
BRISTOL-MYERS SQUIBB CO.
F. HOFFMANN-LA ROCHE LTD.
GSK PLC
HALEON GROUP OF CO.
JOHNSON & JOHNSON SERVICES INC.
OLYMPUS CORP.
PROCTER & GAMBLE
SANOFI
TAKEDA PHARMACEUTICAL CO. LTD.
- Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Highlights of the Global Market for GI Therapeutics and Diagnostics
- Chapter 2 Market Overview
- Overview of the Gastrointestinal System
- Physiology of the GI System and the Role of Each Part in the GI Process
- Chapter 3 Market Dynamics
- Drivers
- Increasing Prevalence of GI Cancer
- Increasing Prevalence of GI Disorders
- Growing Trend toward Screening and Preventive Care
- Growing Adoption and Approval of Biological Drugs
- High Unmet Need
- Challenges
- Loss of Exclusivity and Genericization
- Regulatory and Safety Issues
- Chapter 4 Emerging Technologies and Developments
- Overview
- Incorporation of AI and Other Digital Technologies
- Single-Use Endoscopes
- Focus on Biologics
- Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Global Market for Prescription GI Therapeutics, by Drug Type
- Anti-inflammatories for Bowel Diseases
- Gastrointestinal Cancer
- Proton Pump Inhibitors
- Anti-diarrheals
- Others
- Global Market for Prescription GI Drugs, by Type
- Anti-inflammatories for Bowel Diseases
- Gastrointestinal Cancer Therapeutics
- Proton Pump Inhibitors
- Anti-diarrheals
- Others
- Trends in the Market for Prescription GI Drugs
- Global Market for Over-the-Counter GI Drugs, by Drug Type
- Laxatives
- Antacids
- Proton Pump Inhibitors
- Histamine-2 Blockers and Inhibitors
- Anti-diarrheals
- Global Market for Over-the-Counter GI Drugs, by Type
- Laxatives
- Antacids
- Proton Pump Inhibitors
- Histimine-2 Blockers
- Anti-diarrheals
- Opportunities in the Market of Over-the-Counter GI Medications
- Global Market for Gastrointestinal Endoscopy Equipment
- GI Endoscopes and Visualization Systems
- GI Endotherapy Devices
- Global Market for GI Endoscopy Equipment, by Product
- Technological Trends in the Market for GI Endoscopy
- Global Market for GI Endoscopy Equipment, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Opportunities in the Market for GI Endoscopy Equipment
- Global Market for GI Vaccines
- Rotavirus Vaccine
- Hepatitis
- Hepatitis Vaccine
- Global Market for GI Vaccines, by Disease Type
- Global Market for Rotavirus Vaccines, by Region
- Global Market for Hepatitis Vaccines by Region
- Geographic Breakdown
- Global Market for GI Therapeutics and Diagnostics, by Region
- Market Revenue, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Chapter 6 Competitive Intelligence
- Overview
- Over-the-Counter GI Drugs
- Prescription GI Drugs
- GI Endoscopy Equipment
- GI Vaccines
- GI Disease Types
- Disease Types
- Inflammatory Bowel Diseases
- GI Cancer
- Gastroesophageal Reflux Disease
- Chapter 7 Appendix
- Methodology and Information Sources
- Company Profiles
- ABBVIE INC.
- BAYER AG
- BOSTON SCIENTIFIC CORP.
- BRISTOL-MYERS SQUIBB CO.
- F. HOFFMANN-LA ROCHE LTD.
- GSK PLC
- HALEON GROUP OF CO.
- JOHNSON & JOHNSON SERVICES INC.
- OLYMPUS CORP.
- PROCTER & GAMBLE
- SANOFI
- TAKEDA PHARMACEUTICAL CO. LTD.
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook